
Ultragenyx: Rating Speculative Buy, Playing Setrusumab Data Release (NASDAQ:RARE)
Ozgu Arslan/iStock via Getty Images Investment Thesis Numerous publicly listed entities are now working towards providing unmet medical needs in complex disease segments. For those seeking exposure to breakthroughs for rare genetic diseases, Ultragenyx Pharmaceutical […]